Comments on the three papers by the FDA/CDER research team on the regulatory perspective of the missing data problem

Comments on the three papers by the FDA/CDER research team on the regulatory perspective of the missing data problem

This communication comments on the three papers by the FDA CDER research team on the regulatory perspective of the missing data problem. The focus is on two topics: causal estimand and sensitivity analysis. Copyright © 2016 John Wiley & Sons, Ltd.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Statistics in medicine 2016-07, Vol.35 (17), p.2880-2886
1. Verfasser: Shih, Weichung Joe
Format: Artikel
Sprache:eng
Schlagworte:
Causality
Data Interpretation, Statistical
Humans
Missing data
Research Design
Sensitivity analysis
Statistics as Topic
United States
United States Food and Drug Administration
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This communication comments on the three papers by the FDA CDER research team on the regulatory perspective of the missing data problem. The focus is on two topics: causal estimand and sensitivity analysis. Copyright © 2016 John Wiley & Sons, Ltd.
ISSN:0277-6715
1097-0258
DOI:10.1002/sim.6895